High-Dose Vitamin C Improves Outcomes for Late-Stage Pancreatic Cancer
Adding high dose, intravenous (IV) vitamin C to chemotherapy could potentially double the overall survival among individuals with late-stage metastatic pancreatic cancer from 8 to 16 months, according to research findings published in Redox Biology. The …